Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians

被引:94
作者
Betts, MR
Krowka, J
Santamaria, C
Balsamo, K
Gao, F
Mulundu, G
Luo, CW
NGandu, N
Sheppard, H
Hahn, BH
Allen, S
Frelinger, JA
机构
[1] UNIV N CAROLINA,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27599
[2] CALIF DEPT HLTH SERV,VIRAL & RICKETTSIAL DIS LAB,DIV COMMUNICABLE DIS CONTROL,BERKELEY,CA 94704
[3] UNIV ALABAMA,SCH PUBL HLTH,DEPT MED,BIRMINGHAM,AL 35294
[4] UNIV ALABAMA,SCH PUBL HLTH,DEPT EPIDEMIOL,BIRMINGHAM,AL 35294
[5] UNIV TEACHING HOSP,DEPT LAB MED,LUSAKA,ZAMBIA
[6] UNIV TEACHING HOSP,DEPT PEDIAT,LUSAKA,ZAMBIA
[7] UNIV TEACHING HOSP,DEPT COMMUNITY MED,LUSAKA,ZAMBIA
关键词
D O I
10.1128/JVI.71.11.8908-8911.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have examined cross-clade HIV-specific cytotoxic T-lymphocyte (CTL) activity in peripheral blood of eight Zambian individuals infected with non-B-clade human immunodeficiency virus type 1 (HIV-1). Heteroduplex mobility assay and partial sequence analysis of env and gag genes strongly suggests that all the HIV-infected subjects were infected with clade C HIV-1. Six of eight C-clade HN-infected individuals elicited CTL activity specific for recombinant vaccinia virus-infected autologous targets expressing HIV gag-pol-env derived from B-clade HIV-1 (IIIB). Recognition of individual recombinant HIV-1 B-clade vaccinia virus-infected targets expressing gag, pol, or env was variable among the patients tested, indicating that cross-clade CTL activity is not limited to a single HIV protein. These data demonstrate that HIV clade C-infected individuals can mount vigorous HIV clade B-reactive CTL responses.
引用
收藏
页码:8908 / 8911
页数:4
相关论文
共 29 条
[21]   Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia [J].
Porter, KR ;
Mascola, JR ;
Hupudio, H ;
Ewing, D ;
VanCott, TC ;
Anthony, RL ;
Corwin, AL ;
Widodo, S ;
Ertono, S ;
McCutchan, FE ;
Burke, DS ;
Hayes, CG ;
Wignall, FS ;
Graham, RR .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (01) :1-6
[22]   RECOMBINATION IN AIDS VIRUSES [J].
ROBERTSON, DL ;
HAHN, BH ;
SHARP, PM .
JOURNAL OF MOLECULAR EVOLUTION, 1995, 40 (03) :249-259
[23]   THE NEIGHBOR-JOINING METHOD - A NEW METHOD FOR RECONSTRUCTING PHYLOGENETIC TREES [J].
SAITOU, N ;
NEI, M .
MOLECULAR BIOLOGY AND EVOLUTION, 1987, 4 (04) :406-425
[24]   Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C [J].
Salminen, MO ;
Johansson, B ;
Sonnerborg, A ;
Ayehunie, S ;
Gotte, D ;
Leinikki, P ;
Burke, DS ;
McCutchan, FE .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (14) :1329-1339
[25]  
SETTE A, 1994, J IMMUNOL, V153, P5586
[26]   CROSS-CLADE NEUTRALIZATION OF PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY HUMAN MONOCLONAL-ANTIBODIES AND TETRAMERIC CD4-IGG [J].
TRKOLA, A ;
POMALES, AB ;
YUAN, H ;
KORBER, B ;
MADDON, PJ ;
ALLAWAY, GP ;
KATINGER, H ;
BARBAS, CF ;
BURTON, DR ;
HO, DD ;
MOORE, JP .
JOURNAL OF VIROLOGY, 1995, 69 (11) :6609-6617
[27]   Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 [J].
Trkola, A ;
Purtscher, M ;
Muster, T ;
Ballaun, C ;
Buchacher, A ;
Sullivan, N ;
Srinivasan, K ;
Sodroski, J ;
Moore, JP ;
Katinger, H .
JOURNAL OF VIROLOGY, 1996, 70 (02) :1100-1108
[28]  
TSUJI K, 1991, P 11 HIST WORKSH C H, V1
[29]   Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: Effects of viral variation on cytotoxic T-lymphocyte recognition [J].
Wilson, CC ;
Kalams, SA ;
Wilkes, BM ;
Ruhl, DJ ;
Gao, F ;
Hahn, BH ;
Hanson, IC ;
Luzuriaga, K ;
Wolinsky, S ;
Koup, R ;
Buchbinder, SP ;
Johnson, RP ;
Walker, BD .
JOURNAL OF VIROLOGY, 1997, 71 (02) :1256-1264